Spotlight on fluticasone furoate/umeclidinium/vilanterol in COPD: design, development, and potential place in therapy

COPD is characterized by persistent airflow obstruction caused by exposure to irritants including cigarette smoke, dust, and fumes. According to the latest GOLD (Global Initiative for Chronic Obstructive Lung Disease) guidelines, a combination of inhaled corticosteroids, long-acting β(2) agonists, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lal, Chitra, Strange, Charlie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221559/
https://www.ncbi.nlm.nih.gov/pubmed/28115838
http://dx.doi.org/10.2147/COPD.S114273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221559/
https://www.ncbi.nlm.nih.gov/pubmed/28115838
http://dx.doi.org/10.2147/COPD.S114273

Ejemplares similares